A carregar...
Bruton’s Tyrosine Kinase (BTK) Inhibitor (Ibrutinib)-Suppressed Migration and Invasion of Prostate Cancer
INTRODUCTION: Bruton’s tyrosine kinase (BTK) inhibitors have long been known in the treatment of B-cell malignancies. Recently, BTK inhibitors have also become promising novel treatment reagents for prostate cancer. The current study was designed to investigate expression of BTK in prostate cancer...
Na minha lista:
| Publicado no: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7231774/ https://ncbi.nlm.nih.gov/pubmed/32494164 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S245848 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|